Bortezomib Ester Impurity
| VS CAT No | VS-B004106 |
| CAS No | NA |
| Mol.F. | C29H39BN4O4 |
| Mol.Wt. | 518.5 |
| Inv. Status | Custom Synthesis |
Chemical Name: N-(1-((3-methyl-1-(3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butyl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide
Shipping Temperature: Ambient
Country of Origin: India
Smiles: O=C(NC(CC1=CC=CC=C1)C(NC(B2OC(CC3C(C)(C)C4C3)C4(C)O2)CC(C)C)=O)C5=NC=CN=C5
Bortezomib Ester Impurity is chemically N-(1-((3-methyl-1-(3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butyl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide. Bortezomib Ester Impurity is supplied with detailed characterization data compliant with regulatory guideline. Bortezomib Ester Impurity can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Bortezomib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. Vsquare products are for analytical purpose only and not for human use.